Danaher Co. (NYSE:DHR) Shares Purchased by NBW Capital LLC

NBW Capital LLC raised its position in Danaher Co. (NYSE:DHR) by 3.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,779 shares of the conglomerate’s stock after buying an additional 915 shares during the period. NBW Capital LLC’s holdings in Danaher were worth $6,188,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in DHR. Vanguard Group Inc. lifted its holdings in Danaher by 7.4% in the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate’s stock valued at $15,009,928,000 after acquiring an additional 4,163,657 shares during the last quarter. Wellington Management Group LLP increased its position in Danaher by 12.0% in the 4th quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock worth $6,460,966,000 after purchasing an additional 2,998,161 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Danaher by 10.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,757,558 shares of the conglomerate’s stock worth $3,876,694,000 after purchasing an additional 1,619,586 shares in the last quarter. Capital International Investors raised its holdings in Danaher by 9.1% in the 4th quarter. Capital International Investors now owns 15,956,519 shares of the conglomerate’s stock worth $3,691,735,000 after acquiring an additional 1,334,781 shares during the period. Finally, Norges Bank bought a new position in Danaher in the 4th quarter worth approximately $1,752,382,000. 79.05% of the stock is currently owned by institutional investors.

Insider Activity at Danaher

In other news, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $279.84, for a total value of $4,525,572.48. Following the completion of the transaction, the chief financial officer now owns 29,407 shares in the company, valued at $8,229,254.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Linda Filler sold 3,928 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $279.50, for a total value of $1,097,876.00. Following the completion of the sale, the director now owns 41,149 shares of the company’s stock, valued at approximately $11,501,145.50. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $279.84, for a total value of $4,525,572.48. Following the transaction, the chief financial officer now owns 29,407 shares of the company’s stock, valued at $8,229,254.88. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 113,174 shares of company stock worth $29,775,644. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE DHR traded down $4.01 during trading hours on Friday, hitting $276.75. The company had a trading volume of 3,108,808 shares, compared to its average volume of 3,183,765. The business has a fifty day simple moving average of $256.29 and a 200-day simple moving average of $250.94. The firm has a market cap of $199.87 billion, a P/E ratio of 46.91, a price-to-earnings-growth ratio of 4.62 and a beta of 0.83. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The company had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the company posted $2.05 EPS. The business’s revenue was down 2.9% compared to the same quarter last year. Equities analysts predict that Danaher Co. will post 7.59 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, July 26th. Investors of record on Friday, June 28th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend was Friday, June 28th. Danaher’s dividend payout ratio (DPR) is currently 18.31%.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent research reports. Barclays raised their target price on shares of Danaher from $270.00 to $285.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. Jefferies Financial Group initiated coverage on shares of Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 price objective on the stock. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and upped their price objective for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. The Goldman Sachs Group raised their price objective on shares of Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, TD Cowen lifted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $276.88.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.